Papers - HONDA, Takashi
-
Complete response of advanced hepatocellular carcinoma achieved by sorafenib dose re-escalation after failure of long-term low-dose-sorafenib treatment combined with transcatheter arterial chemoembolization: a case report. Reviewed International journal
Muto H, Kuzuya T, Ito T, Ishizu Y, Honda T, Ishikawa T, Ishigami M, Fujishiro M
Clinical journal of gastroenterology Vol. 13 ( 3 ) page： 397 - 402 2020.6
-
Nonexposed wall-inversion surgery as a novel local resection method for neoplasms in the gastrointestinal tract. Reviewed International journal
Fujishiro M, Furukawa K, Yamamura T, Nakamura M, Honda T, Maeda O, Ishigami M, Kawashima H
Nagoya journal of medical science Vol. 82 ( 2 ) page： 175 - 182 2020.5
-
Sorafenib <i>vs</i>. Lenvatinib as First-line Therapy for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis. Reviewed International journal
Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Ishikawa T, Fujishiro M
Anticancer research Vol. 40 ( 4 ) page： 2283 - 2290 2020.4
-
Initial Experience of Ramucirumab Treatment After Lenvatinib Failure for Patients With Advanced Hepatocellular Carcinoma. Reviewed International journal
Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Ishikawa T, Fujishiro M
Anticancer research Vol. 40 ( 4 ) page： 2089 - 2093 2020.4
-
Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma Reviewed International journal
Kuzuya Teiji, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishikawa Tetsuya, Fujishiro Mitsuhiro
HEPATOLOGY RESEARCH Vol. 50 ( 3 ) page： 374 - 381 2020.3
-
*Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon. Reviewed International coauthorship International journal
Zorron Cheng Tao Pu L, Yamamoto K, Honda T, Nakamura M, Yamamura T, Hattori S, Burt AD, Singh R, Hirooka Y, Fujishiro M
Journal of gastroenterology and hepatology Vol. 35 ( 3 ) page： 433 - 437 2020.3
-
Relationship Between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib. Reviewed International journal
Yamamoto K, Kuzuya T, Honda T*, Ito T, Ishizu Y, Nakamura M, Miyahara R, Kawashima H, Ishigami M, Fujishiro M
Anticancer research Vol. 40 ( 2 ) page： 665 - 676 2020.2
-
Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis. Reviewed International journal
Yoshioka N, Ishigami M, Watanabe Y, Sumi H, Doisaki M, Yamaguchi T, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Haruta JI, Fujishiro M
Scientific reports Vol. 10 ( 1 ) page： 481 2020.1
-
Development of a novel anti-hepatitis B virus agent via Sp1 Reviewed International journal
Hayakawa Michiyo, Umeyama Hideaki, Iwadate Mitsuo, Taguchi Y. -H., Yano Yoshihiko, Honda Takashi, Itami-Matsumoto Saori, Kozuka Ritsuzo, Enomoto Masaru, Tamori Akihiro, Kawada Norifumi, Murakami Yoshiki
SCIENTIFIC REPORTS Vol. 10 ( 1 ) page： 47 2020.1
-
Rapid increase of platelet counts during antiviral therapy in patients with hepatitis C virus infection Reviewed International journal
Ishizu Yoji, Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ito Takanori, Fujishiro Mitsuhiro
HEPATOLOGY RESEARCH Vol. 50 ( 1 ) page： 47 - 56 2020.1
-
Serum Nutritional Markers as Prognostic Factors for Hepatic and Extrahepatic Carcinogenesis in Japanese Patients with Nonalcoholic Fatty Liver Disease. Reviewed International journal
Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Toyoda H, Kumada T, Fujishiro M
Nutrition and cancer Vol. 72 ( 5 ) page： 884 - 891 2020
-
Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion. Reviewed International journal
Tanaka T, Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Ishikawa T, Fujishiro M
Oncology Vol. 98 ( 9 ) page： 621 - 629 2020
-
Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis Reviewed International journal
Nakamura Masanao, Yamamura Takeshi, Maeda Keiko, Sawada Tsunaki, Mizutani Yasuyuki, Ishikawa Eri, Ohashi Ayako, Kajikawa Go, Furukawa Kazuhiro, Ohno Eizaburo, Honda Takashi, Kawashima Hiroki, Ishigami Masatoshi, Fujishiro Mitsuhiro
INTERNAL MEDICINE Vol. 59 ( 23 ) page： 3009 - 3014 2020
-
A Prospective Study of Factors Associated with Abdominal Pain in Patients during Unsedated Colonoscopy Using a Magnifying Endoscope. Reviewed International journal
Suzuki H, Nakamura M, Yamamura T, Maeda K, Sawada T, Mizutani Y, Ishikawa T, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Fujishiro M
Internal medicine (Tokyo, Japan) Vol. 59 ( 15 ) page： 1795 - 1801 2020
-
Sarcopenia impairs health-related quality of life in cirrhotic patients. Reviewed International journal
Ando Y, Ishigami M, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Fujishiro M
European journal of gastroenterology & hepatology Vol. 31 ( 12 ) page： 1550 - 1556 2019.12
-
Feasibility and usefulness of endoscopic ultrasonography-guided shear-wave measurement for assessment of autoimmune pancreatitis activity: a prospective exploratory study. Reviewed International journal
Ohno E, Hirooka Y, Kawashima H, Ishikawa T, Tanaka H, Sakai D, Ishizu Y, Kuzuya T, Nakamura M, Honda T
Journal of medical ultrasonics (2001) Vol. 46 ( 4 ) page： 425 - 433 2019.10
-
Spleen stiffness by 2-D shear wave elastography is the most accurate predictor of high-risk esophagogastric varices in children with biliary atresia Reviewed International journal
Yokoyama Shinya, Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ito Takanori, Hirooka Yoshiki, Tanaka Yujiro, Tainaka Takahisa, Shirota Chiyoe, Chiba Kosuke, Uchida Hiroo, Fujishiro Mitsuhiro
HEPATOLOGY RESEARCH Vol. 49 ( 10 ) page： 1162 - 1168 2019.10
-
Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice. Reviewed International journal
Ma L, Ishigami M, Honda T, Yokoyama S, Yamamoto K, Ishizu Y, Kuzuya T, Hayashi K, Hirooka Y, Goto H.
Digestive diseases and sciences Vol. 64 ( 9 ) page： 2581 - 2590 2019.9
-
Clinical characteristics and outcomes of candidates for second-line therapy, including regorafenib and ramucirumab, for advanced hepatocellular carcinoma after sorafenib treatment. Reviewed International journal
Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Ishikawa T, Hirooka Y, Fujishiro M
Hepatology research : the official journal of the Japan Society of Hepatology Vol. 49 ( 9 ) page： 1054 - 1065 2019.9
-
Complete response by vitamin K2 analog monotherapy in sorafenib-failure advanced hepatocellular carcinoma: A case report. Reviewed International journal
Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Ishikawa T, Hirooka Y, Goto H.
Hepatol Res. Vol. 49 ( 3 ) page： 360-364 2019.3